Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mayer

Showing results (651-660 of 703) with videos related to

Pageof 71
Sort By:
ESMO Open|July 6, 2026
TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancerI Schlam, D Trapani, S-E Kim, et al.
ESMO Open|January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)E Agostinetto, G Pfeiler, D Hlauschek, et al.
The American Journal of Psychiatry|July 13, 2013
A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and AfghanistanMurray A Raskind, Kris Peterson, Tammy Williams, et al.
ESMO Open|July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancerR Jeselsohn, J Fu, Y Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineSaro H Armenian, Christina Lacchetti, Ana Barac, et al.
Breast Cancer Research and Treatment|November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastasesNancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2022
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spikeJun Zhang, Weichun Tang, Hailong Gao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarkerE L Mayer, V Abramson, R Jankowitz, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
ESMO Open|July 27, 2025
Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational studyC Corti, X Chu, P Exman, et al.
Pageof 71

Showing results (651-660 of 703) with videos related to

Sort By:
Pageof 71
ESMO Open|July 6, 2026
TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancerI Schlam, D Trapani, S-E Kim, et al.
ESMO Open|January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)E Agostinetto, G Pfeiler, D Hlauschek, et al.
The American Journal of Psychiatry|July 13, 2013
A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and AfghanistanMurray A Raskind, Kris Peterson, Tammy Williams, et al.
ESMO Open|July 27, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancerR Jeselsohn, J Fu, Y Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice GuidelineSaro H Armenian, Christina Lacchetti, Ana Barac, et al.
Breast Cancer Research and Treatment|November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastasesNancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2022
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spikeJun Zhang, Weichun Tang, Hailong Gao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarkerE L Mayer, V Abramson, R Jankowitz, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
ESMO Open|July 27, 2025
Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational studyC Corti, X Chu, P Exman, et al.
Pageof 71